Name
Expanding Access to OUD Treatment: The Role of Telehealth
Date & Time
Wednesday, April 4, 2018, 9:45 AM - 11:00 AM
Speakers
Judy Bartlett, PhD, MPH, Program Operations Director, Project ECHO, University of New Mexico Health Sciences Center
Patrick Marshalek, MD, Associate Professor, Clinical Faculty, School of Medicine, West Virginia University
Laura Dunlap, PhD, Senior Director, Behavioral Health Services, Policy and Economics Research, RTI International
Peter Yellowlees, MD, MBBS, Vice Chair for Faculty Development and Professor of Psychiatry at the University of California Davis, University of California Davis
Patrick Marshalek, MD, Associate Professor, Clinical Faculty, School of Medicine, West Virginia University
Laura Dunlap, PhD, Senior Director, Behavioral Health Services, Policy and Economics Research, RTI International
Peter Yellowlees, MD, MBBS, Vice Chair for Faculty Development and Professor of Psychiatry at the University of California Davis, University of California Davis
Description
Moderator: Anne L. Burns, RPh, Vice President, Professional Affairs, American Pharmacists Association, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
CE Certified By: AMA,AAFP,ANCC,APA,NAADAC,NASW,NBCC
In rural and economically challenged areas, the healthcare workforce is not adequately sized or trained to handle the opioid epidemic. Telehealth shows promise to relieve these strains by expanding access to critical expertise and resources. This is of particular importance for medication assisted treatment (MAT) of opioid use disorders, which requires a specialized skill set that may not be available in a primary care setting. However, there are policy issues and implementation challenges associated with telehealth that must be considered if it is to be fully utilized and scaled up for wider diffusion. Policies and innovative programs are being implemented to address some of these considerations, yet more needs to be done to understand the opportunities and barriers for telehealth in MAT for opioid use disorders.
This presentation will lay out recent findings from the field, as well as clinical experience on the use of telehealth within behavioral healthcare and, in particular, for the use with MAT. It will discuss current practices in using teleheath for treatment of opioid use disorders, facilitators and barriers to implementing telehealth for behavioral health providers, and ways in which telehealth may affect access to and delivery of treatment for opioid use disorders.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify current strategies that are being implemented for telehealth within behavioral healthcare, and specifically in medication assisted treatment for opioid use disorder, including types of telehealth being used and for whom.
- Describe best practices, barriers and facilitators in using telehealth for opioid use disorder treatment.
- Explain ways in which telehealth may affect access to and delivery of medication assisted treatment for opioid use disorders, especially in rural areas.
CE Certified By: AMA,AAFP,ANCC,APA,NAADAC,NASW,NBCC
In rural and economically challenged areas, the healthcare workforce is not adequately sized or trained to handle the opioid epidemic. Telehealth shows promise to relieve these strains by expanding access to critical expertise and resources. This is of particular importance for medication assisted treatment (MAT) of opioid use disorders, which requires a specialized skill set that may not be available in a primary care setting. However, there are policy issues and implementation challenges associated with telehealth that must be considered if it is to be fully utilized and scaled up for wider diffusion. Policies and innovative programs are being implemented to address some of these considerations, yet more needs to be done to understand the opportunities and barriers for telehealth in MAT for opioid use disorders.
This presentation will lay out recent findings from the field, as well as clinical experience on the use of telehealth within behavioral healthcare and, in particular, for the use with MAT. It will discuss current practices in using teleheath for treatment of opioid use disorders, facilitators and barriers to implementing telehealth for behavioral health providers, and ways in which telehealth may affect access to and delivery of treatment for opioid use disorders.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify current strategies that are being implemented for telehealth within behavioral healthcare, and specifically in medication assisted treatment for opioid use disorder, including types of telehealth being used and for whom.
- Describe best practices, barriers and facilitators in using telehealth for opioid use disorder treatment.
- Explain ways in which telehealth may affect access to and delivery of medication assisted treatment for opioid use disorders, especially in rural areas.